This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (15) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Schifano, F. Articles by Ghodse, A. H. Search for Related Content PubMed PubMed Citation Articles by Schifano, F. Articles by Ghodse, A. H. Social Bookmarking                         What's this?

Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994–2003)

John Corkery

National Programme on Substance Abuse Deaths (npSAD), St George's, University of London, London, UK

Paolo Deluca

Division of Dental Health, St George's, University of London, London, UK

Adenekan Oyefeso

A. Hamid Ghodse

National Programme on Substance Abuse Deaths (npSAD), St George's, University of London, London, UK.

In the last decade, a global trend of escalating ecstasy (MDMA, MDA, MDEA, MBDB) use was observed. Mentions on medical death certificates, last year's ecstasy use, number of drug offenders, seizures, prices and dosage levels figures were used for this descriptive and correlational study. Figures (1994ñ2003) were taken from the UK General Mortality Registers, from the Home Office Statistical Bulletins, from the British Crime Survey and from those reported to both the National Crime Intelligence and Forensic Science Services. A total of 394 ecstasy deaths mentions were here identified from the UK; in 42% of cases ecstasy was the sole drug mentioned. Overall, number of fatalities showed a year-peryear increase and positively correlated with: prevalence of last year's use (p<0.01); number of offenders (p<0.01) and number of seizures (p<0.01) but negatively correlated with ecstasy price (p<0.05). Price negatively correlated with: prevalence of last year's use (p<0.001) and number of seizures (p<0.01); but positively correlated with average MDMA dosage per tablet (p<0.01). MDA, MDEA and MBDB accounted for a significant proportion of tablets only up to 1997, but not afterwards. Increasing production with a concomitant decrease in ecstasy price may have facilitated an increase in consumption levels and this, in turn, may have determined an increase in number of ecstasy deaths mentions. Only medical death certificates and not coroners' reports at the end of their inquests were here analysed; no data were available in respect of other drugs use and toxicology results.

Key Words: MDMA • ecstasy deaths • ecstasy seizures • ecstasy prevalence of use • ecstasy offenders • ecstasy price

Journal of Psychopharmacology, Vol. 20, No. 3, 456-463 (2006)
DOI: 10.1177/0269881106060147


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				F. Schifano and J. Corkery Cocaine/crack cocaine consumption, treatment demand, seizures, related offences, prices, average purity levels and deaths in the UK (1990 2004) J Psychopharmacol, January 1, 2008; 22(1): 71 - 79. [Abstract] [PDF]

				B. Sessa Is there a case for MDMA-assisted psychotherapy in the UK? J Psychopharmacol, March 1, 2007; 21(2): 220 - 224. [Abstract] [PDF]

				A. C. Parrott Ecstasy versus alcohol: Tolstoy and the variations of unhappiness J Psychopharmacol, January 1, 2007; 21(1): 3 - 6. [PDF]